Alzheimer Disease and Associated Disorders Journal Overview
In the critical fight against cognitive decline, academic journals serve as the primary vehicle for sharing breakthroughs in neurology and psychiatry. Alzheimer Disease and Associated Disorders is a specialized, peer-reviewed medical journal dedicated to advancing the understanding, diagnosis, and treatment of Alzheimer's disease and other related dementias.
Published quarterly by Lippincott Williams & Wilkins, the journal provides a platform for original research findings and innovative clinical approaches. By focusing on human-centric research, it bridges the gap between laboratory discovery and bedside patient care.
Key Facts
- Focus: Original research on Alzheimer's disease and associated disorders.
- Disciplines: Neurology and Psychiatry.
- Publication Frequency: Quarterly.
- Impact Factor: 2.1 (2022).
- Publisher: Lippincott Williams & Wilkins (United States).
- Established: 1987.
Scope and Research Focus
The journal prioritizes research involving human subjects to ensure that findings are clinically relevant. This includes epidemiologic studies (the study of how often diseases occur in different groups of people and why), clinical trials, and experimental studies.
A significant portion of the published work focuses on the development of biomarkers—biological molecules found in blood, other body fluids, or tissues that are signs of a normal or abnormal process, or of a condition or disease. These are essential for improving the accuracy of early diagnosis.
Beyond the biological aspects of the disease, the journal also examines the health effects experienced by people living with dementia and the critical challenges faced by their caregivers.
Editorial Content and Structure
To provide a comprehensive view of the field, the journal balances raw data with analytical commentary. While original research is the core, the publication is augmented by several other content types:
- Literature Reviews: Comprehensive summaries of current research.
- Concepts and Hypotheses: Theoretical frameworks and conjectures regarding dementia.
- Brief Reports: Concise updates on specific findings.
- Letters to the Editor: Peer correspondence and academic critiques.
Journal Specifications
| Attribute | Detail |
|---|---|
| ISSN (Print) | 0893-0341 |
| ISSN (Web) | 1546-4156 |
| CODEN | ADADE2 |
| OCLC Number | 13162880 |
| ISO 4 Abbreviation | Alzheimer Dis. Assoc. Disord. |
Frequently Asked Questions
What is the primary goal of the journal?
The journal aims to publish original research findings and new approaches to the diagnosis and treatment of Alzheimer's disease and related disorders.
Who is the publisher of this journal?
It is published by Lippincott Williams & Wilkins, based in the United States.
What types of studies are emphasized in the publication?
The journal emphasizes research in humans, specifically epidemiologic studies, clinical trials, experimental studies, and research on biomarkers.
How often is the journal published?
The journal is published on a quarterly basis.
Does the journal cover the social impact of dementia?
Yes, it includes research on the health effects experienced by people with dementia as well as their caregivers.